Literature DB >> 2351721

Evaluation of a commercial microtiter system (MicroScan) using both frozen and freeze-dried panels for detection of high-level aminoglycoside resistance in Enterococcus spp.

S A Fuller1, D E Low, A E Simor.   

Abstract

The MicroScan system was compared with agar dilution screen plates for the detection of high-level aminoglycoside resistance in 182 enterococcal isolates. Both the frozen Gram-Positive Combo Type 2 and the freeze-dried Type 5 panels were evaluated. The specificity of both panels for the detection of streptomycin and gentamicin resistance was 100%. However, the sensitivities for the detection of gentamicin and streptomycin resistance were 84 and 31%, respectively, for the Type 2 panels and 90 and 41%, respectively, for the Type 5 panels. The sensitivities of these panels for the detection of enterococcal high-level aminoglycoside resistance are inadequate for routine use.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2351721      PMCID： PMC267863          DOI： 10.1128/jcm.28.5.1051-1053.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  18 in total

1.  Resistance to six aminoglycosidic aminocyclitol antibiotics among enterococci: prevalence, evolution, and relationship to synergism with penicillin.

Authors:  S A Calderwood; C Wennersten; R C Moellering; L J Kunz; D J Krogstad
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

2.  Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study.

Authors:  M J Zervos; C A Kauffman; P M Therasse; A G Bergman; T S Mikesell; D R Schaberg
Journal:  Ann Intern Med       Date:  1987-05       Impact factor: 25.391

3.  An aminoglycoside disk sensitivity test for use with enterococci.

Authors:  S L Rosenthal; L F Freundlich
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

4.  Studies on antibiotic synergism against enterococci. I. Bacteriologic studies.

Authors:  R C Moellering; C Wennersten; A N Weinberg
Journal:  J Lab Clin Med       Date:  1971-05

5.  The prevalence of high-level aminoglycoside resistance among enterococci isolated from blood cultures during 1980-1988.

Authors:  C Watanakunakorn
Journal:  J Antimicrob Chemother       Date:  1989-07       Impact factor: 5.790

Review 6.  The enterococcus: "putting the bug in our ears".

Authors:  S A Hoffmann; R C Moellering
Journal:  Ann Intern Med       Date:  1987-05       Impact factor: 25.391

7.  Enterococcal bacteremia in two large community teaching hospitals.

Authors:  D A Malone; R A Wagner; J P Myers; C Watanakunakorn
Journal:  Am J Med       Date:  1986-10       Impact factor: 4.965

8.  Emergence of Streptococcus faecalis isolates with high-level resistance to multiple aminocyclitol aminoglycosides.

Authors:  D P Ikeda; A L Barry; S G Andersen
Journal:  Diagn Microbiol Infect Dis       Date:  1984-06       Impact factor: 2.803

9.  Plasmid-mediated resistance to aminocyclitol antibiotics in group D streptococci.

Authors:  P Courvalin; C Carlier; E Collatz
Journal:  J Bacteriol       Date:  1980-08       Impact factor: 3.490

10.  High-level resistance to gentamicin in clinical isolates of enterococci.

Authors:  B D Mederski-Samoraj; B E Murray
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226
View more
  10 in total

1.  Comparison of microscan broth microdilution, synergy quad plate agar dilution, and disk diffusion screening methods for detection of high-level aminoglycoside resistance in enterococcus species.

Authors:  David R Murdoch; Stanley Mirrett; Lizzie J Harrell; Susan M Donabedian; Marcus J Zervos; L Barth Reller
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

2.  Comparison of the new MicroScan Pos MIC Type 6 panel and AMS-Vitek Gram Positive Susceptibility Card (GPS-TA) for detection of high-level aminoglycoside resistance in Enterococcus species.

Authors:  S Szeto; M Louie; D E Low; M Patel; A E Simor
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

3.  Factors influencing determination of high-level aminoglycoside resistance in Enterococcus faecalis.

Authors:  D F Sahm; S Boonlayangoor; P C Iwen; J L Baade; G L Woods
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

Review 4.  Expert systems in clinical microbiology.

Authors:  Trevor Winstanley; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

5.  Detection of enterococcal high-level aminoglycoside resistance with MicroScan freeze-dried panels containing newly modified medium and Vitek Gram-Positive Susceptibility cards.

Authors:  D Weissmann; J Spargo; C Wennersten; M J Ferraro
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

6.  Detection of high-level aminoglycoside resistance in enterococci other than Enterococcus faecalis.

Authors:  D F Sahm; S Boonlayangoor; J E Schulz
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

7.  Risk factors for acquiring ampicillin-resistant enterococci and clinical outcomes at a Canadian tertiary-care hospital.

Authors:  A E McCarthy; G Victor; K Ramotar; B Toye
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

8.  Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci. National Committee for Clinical Laboratory Standards Study Group on Enterococci.

Authors:  J M Swenson; M J Ferraro; D F Sahm; N C Clark; D H Culver; F C Tenover
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

9.  Susceptibility testing of clinical isolates of Enterococcus faecium and Enterococcus faecalis.

Authors:  M Louie; A E Simor; S Szeto; M Patel; B Kreiswirth; D E Low
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

10.  Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci.

Authors:  J F Boyle; S A Soumakis; A Rendo; J A Herrington; D G Gianarkis; B E Thurberg; B G Painter
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.